Cellecta, Inc.

About

Cellecta, Inc. is a biotechnology company based in Mountain View, California, focused on genomic tools and services for functional genetic screening and immune receptor profiling. Founded in April 2006, the company employs between 11 and 50 people and generates around $6 million in annual revenue. Cellecta offers a range of services, including CRISPR and RNAi screening for drug target and biomarker discovery, available as do-it-yourself kits or full-service solutions. They develop lentiviral constructs and engineered cell lines for gene expression modulation, featuring products like CloneTracker XP™ for single-cell analysis. Their DriverMap™ platform provides T-cell and B-cell receptor profiling, supporting immunotherapy research. Additionally, the DriverMap Human Genome-Wide Targeted Expression Profiling Assay quantifies the expression of nearly 19,000 human protein-coding genes. The company primarily serves biopharmaceutical researchers and academic institutions involved in drug target validation, cancer immunotherapy development, and biomarker discovery, emphasizing sensitivity and scalability in their offerings.